Delivery Order SPE2DB24D1205-SPE2DB25FCWEW
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,084.86 and is for the delivery of 4,566,526,084 units of the drug Vyvanse 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 25, 2024. This appears to be a task order under a larger Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,849.36 firm-fixed-price delivery order is for the provision of 4,563,139,143 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of December 19, 2023. AmerisourceBergen is the prime contractor, with no mentioned subcontractors. This award is part of a larger $999,999,999 Indefinite...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, with a ceiling value of $4,391.50, is for the delivery of 4,568,055,067 units of the prescription medication Vyvanse 40 mg capsules. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 29, 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp, headquartered in...
This federal contract award, with an award ID of SPE2DB22D3009|SPE2DB24FAT96, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,960.58 firm fixed price delivery order is for the supply of 4,564,235,798 Vyvanse 40 mg capsules in 100-count bottles. The contract has an ultimate completion date of April 11, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is also...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 4,566,690 units of the prescription medication Vyvanse 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $3,907.70 and an ultimate completion date of December 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,997,140 units of Vyvanse 40 mg capsules. The $1,393.44 contract has a performance period through March 19, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract with DLA to deliver pharmaceutical products and medical supplies to military treatment...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY3QY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,536.64 firm fixed-price delivery order is for the supply of 4,568,000 units of the 40mg capsule formulation of the medication Vyvanse. The contract has an ultimate completion date of April 23, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 40 mg capsules. The contract has a total ceiling value of $1,010.82 and a period of performance through April 17, 2025. It is a delivery order contract with a firm-fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the delivery of 4,565,423,496 units of Vyvanse 40 mg capsules. The contract has a ceiling value of $1,972.15 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 13, 2024. The contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded...
This federal contract award is for the delivery of 4,568,194,504 units of the prescription medication Vyvanse 40 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $2,048.31 and a period of performance through May 9, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....